Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · Real-Time Price · USD
1.800
-0.060 (-3.23%)
Nov 4, 2024, 4:00 PM EST - Market closed

BCLI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
10136014514397
Upgrade
Market Cap Growth
-66.82%-77.69%-58.70%1.59%47.63%31.62%
Upgrade
Enterprise Value
7155712311697
Upgrade
Last Close Price
1.804.0924.6060.0067.8764.20
Upgrade
PE Ratio
--0.68-2.47-5.88-4.25-4.03
Upgrade
PB Ratio
-7.64-2.75-19.887.504.03-7.92
Upgrade
P/FCF Ratio
-1.86-0.65-3.10-5.46-4.02-8.26
Upgrade
P/OCF Ratio
-1.87-0.65-3.10-5.52-4.06-8.60
Upgrade
EV/EBITDA Ratio
-1.70-0.70-2.32-5.06-3.67-4.26
Upgrade
EV/EBIT Ratio
-1.67-0.69-2.29-5.00-3.65-4.23
Upgrade
EV/FCF Ratio
-1.89-0.72-2.94-4.62-3.25-8.30
Upgrade
Debt / Equity Ratio
-0.27-0.26-1.360.260.20-0.19
Upgrade
Debt / FCF Ratio
-0.07-0.06-0.21-0.19-0.20-0.20
Upgrade
Quick Ratio
0.460.170.353.513.760.17
Upgrade
Current Ratio
0.500.240.353.693.850.19
Upgrade
Return on Equity (ROE)
---297.38%-89.25%-273.75%-
Upgrade
Return on Assets (ROA)
-178.20%-211.70%-82.24%-38.09%-68.53%-161.87%
Upgrade
Return on Capital (ROIC)
---121.68%-45.71%-120.66%-
Upgrade
Earnings Yield
-133.21%-128.57%-40.51%-16.85%-22.27%-24.03%
Upgrade
FCF Yield
-151.11%-153.13%-32.29%-18.33%-24.90%-12.11%
Upgrade
Buyback Yield / Dilution
-54.99%-17.99%-0.90%-21.22%-36.25%-9.54%
Upgrade
Total Shareholder Return
-54.99%-17.99%-0.90%-21.22%-36.25%-9.54%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.